Stockreport

FDA approves Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF 1.5 mg starting dose available in early January for $149 per month with savings offers; Wegovy ® pill is being produced in the US and robust supply is on-hand Wegovy [Read more]